NDC 0121-4027 – Lithium
Lithium Citrate 8 meq/5mL · Solution · Oral
Product NDC0121-4027
Product details
- Brand name
- Lithium
- Generic name
- Lithium
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA070755
- Marketed since
- April 14, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Mood Stabilizer
Active ingredients
- Lithium Citrate 8 meq/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-4027-94 | 3 TRAY in 1 CASE (0121-4027-94) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-4027-05) | Apr 14, 2026 |
Other Lithium products
- 72888-172 Lithium Citrate 8 meq/5mL · Solution · Advagen Pharma Ltd
- 17856-1172 Lithium Citrate 8 meq/5mL · Solution · Atlantic Biologicals Corp.
- 0121-1027 Lithium Citrate 8 meq/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 68094-077 Lithium Citrate 8 meq/5mL · Solution · Precision Dose, Inc.
- 70518-4227 Lithium Citrate 8 meq/5mL · Solution · REMEDYREPACK INC.
- 71656-072 Lithium Citrate 8 meq/5mL · Solution · Saptalis Pharmaceuticals, LLC
- 60986-1019 Lithium Bromide 3 [hp_X]/mL · Liquid · Marco Pharma International LLC.